Pancreatic Cancer Research

ResearcherUniversity of MichiganNo recent work listed

Douglas J. Hartman

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8962-8993; OpenAlex author ID A5015029502. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: 1 paper · 2015: none · 2016: 1 paper · 2017: none · 2018: 1 paper

Papers 4

  1. Systemic Depletion of Nerve Growth Factor Inhibits Disease Progression in a Genetically Engineered Model of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1097/mpa.0000000000001090↗
  2. Ablation of sensory neurons in a genetic model of pancreatic ductal adenocarcinoma slows initiation and progression of cancer. Co-author DOI 10.1073/pnas.1512603113↗
  3. Neuroplastic changes occur early in the development of pancreatic ductal adenocarcinoma. Co-author DOI 10.1158/0008-5472.can-13-2050↗
  4. Assessing treatment effect in pancreatic cancer. Co-author DOI 10.5858/arpa.2011-0144-ra↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Brian M Davis · 3 shared papers, 2014–2018 · strength 0.20
  2. Jami Lynn Saloman · 2 shared papers, 2016–2018 · strength 0.16
  3. Andrew D. Rhim · 2 shared papers, 2014–2016 · strength 0.10
  4. Aatur Dilip Singhi · 1 shared paper, 2018 · strength 0.10
  5. Alyssa M. Krasinskas · 1 shared paper, 2012 · strength 0.06
  6. Howard C. Crawford · 1 shared paper, 2016 · strength 0.06
  7. Rachelle E. Stopczynski · 1 shared paper, 2014 · strength 0.04
  8. Haoqiang Ying · 1 shared paper, 2014 · strength 0.04
  9. Ronald Anthony Depinho · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.